Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid

by Zhou, S., Kestell, P., Baguley, B.C., Paxton, J.W.
Published 2014

Determination of the investigational anti-cancer drug 5,6- dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence...

by Zhou, S., Feng, X., Kestell, P., Baguley, B.C., Paxton, J.W.
Published 2014

Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4- acetic acid and its acyl glucuronide by human intestinal Caco-2 cells

by Zhou, S., Feng, X., Kestell, P., Paxton, J.W., Baguley, B.C., Chan, E.
Published 2014

Correspondence re: J. Lu et al., Thalidomide Metabolites in Mice and Patients with Multiple Myeloma. Clin. Cancer Res., 9: 1680-1688, 2003 [1] (multiple letters)

by Zhou, S., Ching, L.-M., Baguley, B.C., Kestell, P., Palmer, B.D., Lu, J.
Published 2014